Heart Rate News and Research

RSS

Heart rate is determined by the number of heartbeats per unit of time, typically expressed as beats per minute (BPM), it can vary with as the body's need for oxygen changes, such as during exercise or sleep.

Small, ingestible sensor can track patient medication intake, activity levels; Technology to be tested for TB treatment

The FDA last month approved for use a small ingestible sensor that, when embedded into a pill, can help "keep track of whether a patient is taking their medicine on time," Reuters reports.

29 Aug 2012

Positive results from CardioKinetix’s Parachute device clinical trial on ischemic heart failure

CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, today announced clinical results showing meaningful and sustained low clinical events for patients with ischemic heart failure three years following Percutaneous Ventricular Restoration (PVR) therapy with the first-of-its-kind catheter-based Parachute™ Ventricular Partitioning Device.

28 Aug 2012

Researchers now add electronic sensors to tissue scaffolds

To control the three-dimensional shape of engineered tissue, researchers grow cells on tiny, sponge-like scaffolds. These devices can be implanted into patients or used in the lab to study tissue responses to potential drugs.

28 Aug 2012

Renal denervation leads to better outcomes than standard drug treatment in patients with AHF

Renal denervation leads to better outcomes than standard drug treatment in patients with advanced heart failure, according to research presented at ESC Congress 2012. The results of the Olomouc I pilot study were presented by Dr Miloš Táborský from the University Hospital Olomouc.

27 Aug 2012

Study explores gender-related differences in patients hospitalized for acute heart failure

Women with acute heart failure have similar in-hospital mortality to men but are less treated in the real world, according to results from the global ALARM-HF registry presented today at the ESC Congress 2012. The findings were presented by Dr John T. Parissis from Greece.

27 Aug 2012

Renal denervation improves depression, QOL and stress in patients with resistant hypertension

Renal sympathetic denervation improves anxiety, depression, quality of life and stress in patients with resistant hypertension, according to research presented at ESC Congress 2012 by Dr Denise Fischer from Saarland University Hospital.

27 Aug 2012

Consuming energy drinks can exert acute positive benefits on myocardial performance

Consuming energy drinks can exert acute positive benefits on myocardial performance, according to research presented today at the ESC Congress by Dr Matteo Cameli from University of Siena.

27 Aug 2012

Electronic cigarettes far less harmful and may be beneficial to health

Smoking is the most preventable risk factor for cardiac and lung disease and is expected to cause 1 billion deaths during the 21st century. Electronic cigarettes have been marketed in recent years as a safer habit for smokers, with several millions of people already using them worldwide.

26 Aug 2012

Parachute device improves outcomes in patients with ischemic heart failure

A novel non-invasive device which separates healthy and damaged heart muscle and restores ventricle function improves 3 year outcomes in patients with ischemic heart failure, according to research presented at the ESC Congress 2012.

26 Aug 2012

Miniaturized wireless sensors can save lives of wounded soldiers

Early detection of blood loss to save the lives of soldiers wounded on the battlefield is the goal of a three-year research and development project to be launched this fall at Worcester Polytechnic Institute (WPI). Funded by a $1.9 million grant from the U.S. Army, the research will be conducted in collaboration with the University of Massachusetts Medical School (UMMS).

22 Aug 2012

Sotera Wireless receives FDA 510(k) clearance for ViSi Mobile System

Sotera Wireless, Inc. announced today that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its full ViSi Mobile System and is commencing sales to hospitals nationwide.

22 Aug 2012

CHD patients do not need to rule out high-intensity exercise

Findings from a retrospective study show that patients with coronary heart disease who engage in high-intensity exercise have a similarly low risk for a cardiovascular event as those engaging in moderate-intensity exercise.

21 Aug 2012

First Edition: August 20, 2012

Today's headlines focus on how the Medicare story is continuing to unfold on the presidential campaign trail.

20 Aug 2012

No aping around after anesthetic combination

A combination of medetomidine and ketamine administered intramuscularly to chimpanzees, orangutans, and gorillas results in reliable immobilization for both the animals and personnel handling them, report researchers.

15 Aug 2012

Cardiovascular control continues despite low pulse pressure in LVAD patients

Patients implanted with continuous-flow left ventricular assist devices have low pulse pressure levels but are nevertheless able to maintain cardiovascular control through baroreflexes, German and US scientists have discovered.

14 Aug 2012

FDA approves Intelliject's Auvi-Q for anaphylaxis

Intelliject, Inc. announced that the U.S. Food and Drug Administration approved Auvi-Q (epinephrine injection, USP) for the emergency treatment of life-threatening allergic reactions in people who are at risk or have a history of anaphylaxis. This is the first-and-only compact auto-injector with audio and visual cues that guide patients and caregivers step-by-step through the injection process.

13 Aug 2012